Skip to content

Search

Showing results for "vitamin d asthma"

Air pollution during pregnancy and lung development in the child

Air pollution exposure has increased in recent years and there is evidence that exposure to particulate matter can lead to adverse respiratory outcomes.

Hierarchy and molecular properties of house dust mite allergens

The allergenic load of house dust mite allergy is largely constituted by a few proteins with a hierarchical pattern of allergenicity.

Immunotherapy of allergic diseases by bacterial products

Allergic diseases are characterized by excessive immunoglobulin E (IgE) production, mast cell degranulation, tissue eosinophilia and mucus hypersecretion

Program Manager - The Kids Respiratory Research Centre

The Opportunity The diverse activities of the newly established The Kids Respiratory Research Centre will be coordinated by the Program Manager who

How the Australian bushfires can impact your family’s physical health

Bushfires can have a considerable impact on our physical and mental health, with some symptoms lasting long after the blaze is extinguished. And our children are amongst the most vulnerable.

Michael Chaney awarded Fiona Stanley Medal

Wesfarmers Managing Director Michael Chaney has been honoured with the Fiona Stanley Medal for his commitment to improving child health and wellbeing.

Testing the meningococcal conjugate vaccine MenACWY-TT in toddlers

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical

Gateway to Allergy Prevention

This project aims to examine whether maternal probiotic supplementation promotes an enhanced immunomodulatory breastmilk composition likely to promote infant oral tolerance, and reduce food allergy in breastfed children.

Clinical Trials, Platforms & Cohorts

Learn more about all of the Clinical Trials, Platforms & Cohorts at the Wal-yan respiratory centre.

Fighting pseudomonas aeruginosa and nontypeable

Fighting pseudomonas aeruginosa and nontypeable haemophilus influenzae biofilms with host defence peptide as a novel step forward in the treatment of